Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Deciphera Pharmaceuticals
1601 Trapelo Road, Suite 152
Waltham, MA 02451
Phone: 781-209-6400

Deciphera Pharmaceuticals seeks to improve treatment for patients with cancer by designing kinase inhibitor therapies that target the hallmarks of cancer biology. We specifically design our small molecule compounds to simultaneously block multiple cancer signaling mechanisms in the tumor cell and the tumor microenvironment to prevent growth and spread. Deciphera's unique approach represents an important advance over current therapies in the durability of kinase inhibition and resiliency to genetic mutations to provide greater benefit across a range of cancers. Deciphera's business strategy is to advance its drug candidates for genetically defined cancers and cancers that target the tumor microenvironment through both proprietary and partnered programs.

Key Contact
Michael D. Taylor
Funding Events

09/21/15 $75,000,000 Series B New Leaf Venture Partners
01/05/16 $90,000,000 Series B New Leaf Venture Partners
06/01/17 $52,000,000 Series C New Leaf Venture Partners
Redmile Group
Sphera Global Healthcare
Viking Global Investors